We propose that increased active nuclear SREBP1 is the driver for increased lipogenic gene expression (Srebp1 and Fas) and the subsequent obesity-independent hepatic steatosis that was observed (Fig. 5A; Proposed model). This evidence concerns the gene SREBF1 and fatty liver disease.